|
|
|
|
|
25.03.26 - 23:31
|
XFRA: DIVIDEND/INTEREST INFORMATION - 27.03.2026 - US6373722023 (XETRA)
|
|
|
Das Instrument NR1A US6373722023 NATL RESH CORP. DL-,001 EQUITY wird cum Dividende/Zinsen gehandelt am 26.03.2026 und ex Dividende/Zinsen am 27.03.2026
The instrument NR1A US6373722023 NATL RESH CORP. DL-,001 EQUITY has its pre-dividend/interest day on 26.03.2026 and its ex-dividend/interest day on 27.03.2026...
|
|
|
24.03.26 - 14:06
|
pH7 Technologies Expands Vancouver Facility to Strengthen North American Supply of Critical Platinum Group Metals (Business Wire)
|
|
|
Expansion of operating Vancouver processing facility increases recovery of platinum, palladium and rhodium while reducing wastewater, energy use and carbon footprintVANCOUVER, British Columbia--(BUSINESS WIRE)--pH7 Technologies Inc., a Vancouver-based critical metals processing company, today announced it is expanding its operating metals processing facility in Vancouver to scale the recovery of platinum group metals (PGMs) and strengthen regional supply chains for critical metals.
pH7 Technologies is receiving advisory services and up to $4 million in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to help advance the company's proprietary metallurgical processing technologies.
The project will accelerate the development and scale-up of pH7's organo-electrochemical processes for recovering platinum, palladium, and rhodium from secondary materials. These platinum group metals are critical components in technologies ranging from hydrogen production a...
|
|
|
|
|
18.03.26 - 21:06
|
Xanadu, the University of Toronto and the National Research Council of Canada Unveil Quantum Algorithms for Lithium-ion Battery Simulations (GlobeNewswire EN)
|
|
|
TORONTO, March 18, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, has today announced a novel quantum computational algorithm to accelerate the discovery and analysis of next-generation battery materials. Published as a pre-print article, Xanadu's new research, in collaboration with the University of Toronto and the National Research Council of Canada (NRC) as part of the NRC's Applied Quantum Computing Challenge program, demonstrates how fault-tolerant quantum computers can solve critical challenges to enable the practical application of higher-capacity lithium-excess cathode active materials for lithium batteries....
|
|
|
|
|
09.03.26 - 21:33
|
NRC Health Announces Board Authorization of $60 Million Share Repurchase Program (Business Wire)
|
|
|
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced that its Board of Directors authorized a stock repurchase program of up to $60 million of the company's outstanding common stock through March 31, 2028.
NRC Health may repurchase shares from time to time in the open market, through privately negotiated transactions and/or other means in compliance with the Securities Exchange Act of 1934 and the rules and regulations thereunder. Open market repurchases may be structured to occur in accordance with the requirements of Rule 10b-18 under the Exchange Act. The Company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of shares of common stock under this authorization. The timing, manner, price, and amount of any repurchases will be determined by NRC Health at its discretion, and will depend on a variety of factors, including business, economic and market condit...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.02.26 - 15:03
|
NRC Health Announces Fourth Quarter 2025 Results (Business Wire)
|
|
|
Fourth quarter TRCV* increased 8% year-over-year to $144.1 million
Cash flow from operations increased 13% year-over-year to $7.2 millionLINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the fourth quarter 2025.
“Our fourth quarter results reflect the strong, disciplined execution happening across NRC Health and the deep trust our customers place in us,” said Trent Green, CEO of NRC Health. “With TRCV reaching $144 million and momentum building across our portfolio, we finished the year with a strong foundation for continued execution. As healthcare leaders navigate unprecedented complexity, our mission—turning human understanding into meaningful, measurable action—has never been more essential. I'm incredibly proud of our teams and energized by the opportunity ahead as we continue helping our partners elevate the experiences of the people they serve.”
Fourth Quarte...
|
|
|
|